This new cholesterol drug could reduce the risk of dying
A new study published on Saturday found that the cholesterol drug alirocumab is linked to a lower mortality risk of 15%. This article was originally published on LongevityFacts. Brady Hartman is the author.
According to a recent study, the cholesterol-lowering drug, alirocumab, was associated with a 15% reduced risk of death and a similar reduction in cardiovascular events such as stroke and heart attack.
This is the first time that a drug to lower cholesterol has been able to reduce deaths since statins like Crestor and Lipitor were introduced decades ago.
Source:
